Clinical trial · Observational
Evaluation of Splenic Irradiation in Chronic Lymphatic Leukemia
Evaluation of Splenic Irradiation in Chronic Lymphatic Leukemia (CLL)
NCT02020109CI-TRIAL-00032369withdrawnClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Logistics and financial
Summary
Brief summary (as posted)
Retrospective evaluation on the effect of splenic irradiation on clinical and hematological response and toxicity in patients with chronic lymphatic leukaemia (CLL).
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Leukemia, Chronic Lymphatic | Chronic Lymphocytic Leukemia | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| splenic irradiation | Radiation | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Patients with Chronic Lymphatic Leukemia
- description
- Patients with Chronic Lymphatic Leukemia treated with splenic irradiation
- interventionNames
- Radiation: splenic irradiation
Primary outcomes (1)
- measure
- Clinical and haematological response
- timeFrame
- 13 years
- description
- Clinical and haematological response measured by number of leucocytes and thrombocytes during and after irradiation. Hemoglobin and size of spleen during and after irradiation in the time period 2000 tot 2013
Secondary outcomes (3)
- measure
- Progression of chronic Lymphatic leukaemia
- timeFrame
- 13 years
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * patients with chronic lymphatic leukaemia. Exclusion Criteria: * none
References
Publications (0)
Data not yet available
No reference posted for this study.